iTonic Holdings Ltd
About iTonic Holdings Ltd
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $523.0K
- Net income
- -$5.1M
- Total assets
- $9.1M
- Market cap
- $4.8M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $4.8M
- Shares outstanding
- 11.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 5, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $5.1M in FY2025.
- Trading 30% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review iTonic Holdings Ltd.
Write a review
News about iTonic Holdings Ltd
News & sentiment via Polygon.io
